Meitav Dash Investments LTD Neuro Sense Therapeutics Ltd. Transaction History
Meitav Dash Investments LTD
- $6.92 Billion
- Q3 2025
A detailed history of Meitav Dash Investments LTD transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Meitav Dash Investments LTD holds 40,000 shares of NRSN stock, worth $39,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,000
Previous 40,000
-0.0%
Holding current value
$39,200
Previous $76,000
34.21%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NRSN
# of Institutions
10Shares Held
293KCall Options Held
0Put Options Held
0-
Squarepoint Ops LLC New York, NY95.4KShares$93,4670.0% of portfolio
-
Morgan Stanley New York, NY66.4KShares$65,0720.0% of portfolio
-
Ubs Group Ag30.9KShares$30,2530.0% of portfolio
-
Two Sigma Investments, LP New York, NY21.1KShares$20,6640.0% of portfolio
-
Commonwealth Equity Services, LLC21.1KShares$20,6580.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $11.4M